glp-1 in europe Uptake by Country: Where Ozempic and Mounjaro are Booming 2026 Oral GLP-1 Market to Rise

majority of these firms are based in China (36%) and the US (28%)

FDA-approved GLP-1 medications in the United States include both daily and weekly formulations

The majority of [our customers] I actually don't know the reason, but I think it's much simpler they're choosing to cover the drugs with lifestyle support alongside," Duffy said

Patients with higher starting weights often respond well to tirzepatide dual mechanism

The holdings include growth players like Nvidia and Microsoft (MSFT), alongside value plays like Berkshire Hathaway (BRK.A) and JPMorgan Chase (JPM)

Consult with One of Our Providers Review your results together via telehealth or in-clinic